Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Times Interest Earned (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Times Interest Earned for 4 consecutive years, with $4.91 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 103.65% to $4.91 in Q3 2025 year-over-year; TTM through Sep 2025 was -$91.4, a 18.43% increase, with the full-year FY2024 number at -$96.82, up 62.21% from a year prior.
  • Times Interest Earned was $4.91 for Q3 2025 at bioAffinity Technologies, up from -$5.21 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4.91 in Q3 2025 to a low of -$1307.6 in Q2 2023.
  • A 4-year average of -$229.62 and a median of -$88.22 in 2024 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: plummeted 76214.65% in 2023, then soared 103.65% in 2025.
  • bioAffinity Technologies' Times Interest Earned stood at -$18.19 in 2022, then crashed by 818.69% to -$167.06 in 2023, then surged by 78.57% to -$35.81 in 2024, then surged by 113.7% to $4.91 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Times Interest Earned are $4.91 (Q3 2025), -$5.21 (Q2 2025), and -$169.66 (Q1 2025).